{
  "ticker": "TECH",
  "year": 2022,
  "quarter": 3,
  "last_updated": "2025-04-15T15:30:14.989776",
  "count": 41,
  "transactions": [
    {
      "id": 12964,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-23",
      "transaction_shares": "663",
      "transaction_price": "150.78",
      "transaction_type": "M",
      "shares_after_transaction": "3801"
    },
    {
      "id": 29184,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-23",
      "transaction_shares": "663",
      "transaction_price": "150.78",
      "transaction_type": "M",
      "shares_after_transaction": "3801"
    },
    {
      "id": 54674,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-23",
      "transaction_shares": "663",
      "transaction_price": "150.78",
      "transaction_type": "M",
      "shares_after_transaction": "3801"
    },
    {
      "id": 91107,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-23",
      "transaction_shares": "663",
      "transaction_price": "150.78",
      "transaction_type": "M",
      "shares_after_transaction": "3801"
    },
    {
      "id": 134963,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-23",
      "transaction_shares": "663",
      "transaction_price": "150.78",
      "transaction_type": "M",
      "shares_after_transaction": "3801"
    },
    {
      "id": 12967,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "HIGGINS JOHN L",
      "reporting_owner_cik": "0001208906",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "3400",
      "transaction_price": "66.90",
      "transaction_type": "M",
      "shares_after_transaction": "8006"
    },
    {
      "id": 29189,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "HIGGINS JOHN L",
      "reporting_owner_cik": "0001208906",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "3400",
      "transaction_price": "66.90",
      "transaction_type": "M",
      "shares_after_transaction": "8006"
    },
    {
      "id": 54679,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "HIGGINS JOHN L",
      "reporting_owner_cik": "0001208906",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "3400",
      "transaction_price": "66.90",
      "transaction_type": "M",
      "shares_after_transaction": "8006"
    },
    {
      "id": 91115,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "HIGGINS JOHN L",
      "reporting_owner_cik": "0001208906",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "3400",
      "transaction_price": "66.90",
      "transaction_type": "M",
      "shares_after_transaction": "8006"
    },
    {
      "id": 134975,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "HIGGINS JOHN L",
      "reporting_owner_cik": "0001208906",
      "reporting_owner_position": null,
      "transaction_date": "2022-08-10",
      "transaction_shares": "3400",
      "transaction_price": "66.90",
      "transaction_type": "M",
      "shares_after_transaction": "8006"
    },
    {
      "id": 12963,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Furlow Brenda S.",
      "reporting_owner_cik": "0001443851",
      "reporting_owner_position": "SVP - General Counsel",
      "transaction_date": "2022-08-08",
      "transaction_shares": "563",
      "transaction_price": "177.32",
      "transaction_type": "M",
      "shares_after_transaction": "6523"
    },
    {
      "id": 29182,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Furlow Brenda S.",
      "reporting_owner_cik": "0001443851",
      "reporting_owner_position": "SVP - General Counsel",
      "transaction_date": "2022-08-08",
      "transaction_shares": "563",
      "transaction_price": "177.32",
      "transaction_type": "M",
      "shares_after_transaction": "6523"
    },
    {
      "id": 54672,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Furlow Brenda S.",
      "reporting_owner_cik": "0001443851",
      "reporting_owner_position": "SVP - General Counsel",
      "transaction_date": "2022-08-08",
      "transaction_shares": "563",
      "transaction_price": "177.32",
      "transaction_type": "M",
      "shares_after_transaction": "6523"
    },
    {
      "id": 91105,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Furlow Brenda S.",
      "reporting_owner_cik": "0001443851",
      "reporting_owner_position": "SVP - General Counsel",
      "transaction_date": "2022-08-08",
      "transaction_shares": "563",
      "transaction_price": "177.32",
      "transaction_type": "M",
      "shares_after_transaction": "6523"
    },
    {
      "id": 134961,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Furlow Brenda S.",
      "reporting_owner_cik": "0001443851",
      "reporting_owner_position": "SVP - General Counsel",
      "transaction_date": "2022-08-08",
      "transaction_shares": "563",
      "transaction_price": "177.32",
      "transaction_type": "M",
      "shares_after_transaction": "6523"
    },
    {
      "id": 12960,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Hippel James",
      "reporting_owner_cik": "0001603594",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "3938",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14693"
    },
    {
      "id": 12962,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "16918",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "251960"
    },
    {
      "id": 12974,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-07",
      "transaction_shares": "2363",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4352"
    },
    {
      "id": 29177,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Hippel James",
      "reporting_owner_cik": "0001603594",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "3938",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14693"
    },
    {
      "id": 29181,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "16918",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "251960"
    },
    {
      "id": 29201,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-07",
      "transaction_shares": "2363",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4352"
    },
    {
      "id": 54666,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Hippel James",
      "reporting_owner_cik": "0001603594",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "3938",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14693"
    },
    {
      "id": 54671,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "16918",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "251960"
    },
    {
      "id": 54691,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-07",
      "transaction_shares": "2363",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4352"
    },
    {
      "id": 91098,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Hippel James",
      "reporting_owner_cik": "0001603594",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "3938",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14693"
    },
    {
      "id": 91103,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "16918",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "251960"
    },
    {
      "id": 91127,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-07",
      "transaction_shares": "2363",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4352"
    },
    {
      "id": 134951,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Hippel James",
      "reporting_owner_cik": "0001603594",
      "reporting_owner_position": "Chief Financial Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "3938",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "14693"
    },
    {
      "id": 134957,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "Chief Executive Officer",
      "transaction_date": "2022-08-07",
      "transaction_shares": "16918",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "251960"
    },
    {
      "id": 134992,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kelderman Kim",
      "reporting_owner_cik": "0001739054",
      "reporting_owner_position": "Pres. Diagnostics & Genom",
      "transaction_date": "2022-08-07",
      "transaction_shares": "2363",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "4352"
    },
    {
      "id": 12973,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-28",
      "transaction_shares": "45346",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "262749"
    },
    {
      "id": 29198,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-28",
      "transaction_shares": "45346",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "262749"
    },
    {
      "id": 54688,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-28",
      "transaction_shares": "45346",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "262749"
    },
    {
      "id": 91124,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-28",
      "transaction_shares": "45346",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "262749"
    },
    {
      "id": 134989,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-28",
      "transaction_shares": "45346",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "262749"
    },
    {
      "id": 2864,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    },
    {
      "id": 12971,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    },
    {
      "id": 29195,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    },
    {
      "id": 54685,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    },
    {
      "id": 91121,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    },
    {
      "id": 134986,
      "issuer_name": "BIO-TECHNE Corp",
      "reporting_owner": "Kummeth Charles R.",
      "reporting_owner_cik": "0001534980",
      "reporting_owner_position": "CHIEF EXECUTIVE OFFICER",
      "transaction_date": "2022-07-06",
      "transaction_shares": "50000",
      "transaction_price": "108.49",
      "transaction_type": "M",
      "shares_after_transaction": "248338"
    }
  ]
}